Umer Rappat's questions to Teva Pharmaceutical Industries Ltd (TEVA) leadership • Q2 2025
Question
Umer Rappat of Evercore ISI inquired about the expected discount range for AUSTEDO under IRA negotiations and the potential impact of newly announced European tariffs.
Answer
President & CEO Richard Francis stated the company would not comment on ongoing IRA negotiations with CMS. Regarding tariffs, Francis and EVP & CFO Eli Kalif explained that Teva has a flexible value chain with limited China exposure and has absorbed confirmed tariffs into its 2025 guidance, seeing no meaningful impact from the ambiguous European announcements at this time.